Heat shock protein upregulation protects against pacing-induced myolysis in HL-1 atrial myocytes and in human atrial fibrillation

Journal of Molecular and Cellular Cardiology

Volumn 41, Issue 3, 2006, Pages 555-562

  Brundel, Bianca J J M ^a   Henning, Robert H ^a   Ke, Lei ^a   van Gelder, Isabelle C ^a   Crijns, Harry J G M ^b   Kampinga, Harm H ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Atrial Fibrillation; Geranylgeranylacetone; Heat shock protein; HL 1; Hsp27; Hsp70; Myocytes; Myolysis

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEAT SHOCK COGNATE PROTEIN 70; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 27; HEAT SHOCK PROTEIN 40; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 90; TEPRENONE; VERAPAMIL;

ADULT; ANIMAL CELL; ARTICLE; CLINICAL ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOLYSIS; GENETIC TRANSFECTION; HEART ATRIUM FIBRILLATION; HEART MUSCLE CELL; HEART PACING; HEART PROTECTION; HUMAN; MOUSE; NONHUMAN; PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; SINUS RHYTHM; WESTERN BLOTTING;

AGED; ANIMALS; ATRIAL APPENDAGE; ATRIAL FIBRILLATION; DITERPENES; HEART DISEASES; HEAT-SHOCK PROTEINS; HSP27 HEAT-SHOCK PROTEINS; HSP70 HEAT-SHOCK PROTEINS; HUMANS; MICE; MIDDLE AGED; MYOCYTES, CARDIAC; NEOPLASM PROTEINS; TIME FACTORS; UP-REGULATION;

EID: 33748439366     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2006.06.068     Document Type: Article

References (39)

1. Godtfredsen J. Etiology, course and prognosis. A follow-up study of 1212 cases (1975), University of Copenhagen, Copenhagen
2. Nattel S. New ideas about atrial fibrillation 50 years on. Nature 415 (2002) 219-226
3. Ausma J., Wijffels M., Thone F., Wouters L., Allessie M., and Borgers M. Structural changes of atrial myocardium due to sustained atrial fibrillation in the goat. Circulation 96 (1997) 3157-3163
4. Allessie M., Ausma J., and Schotten U. Electrical, contractile and structural remodeling during atrial fibrillation. Cardiovasc. Res. 54 (2002) 230-246
5. Thijssen V.L.J.L., Ausma J., Liu G.S., Allessie M., Eys G.J.J.M., and Borgers M. Structural changes of atrial myocardium during chronic atrial fibrillation. Cardiovasc. Pathol. 9 (2000) 17-28
6. Ausma J., Van der Velden H.M.W., Lenders M.H., Van Ankeren E.P., Jongsma H.J., Ramaekers F., et al. Reverse structural and gap-junctional remodeling after prolonged atrial fibrillation in the goat. Circulation 107 (2003) 2051-2058
7. Verheule S., Sato T., Everett T., Engle S.K., Otten D., Rubert-von der Lohe M., et al. Increased vulnerability to atrial fibrillation in transgenic mice with selective atrial fibrosis caused by overexpression of TGF-b1. Circ. Res. 94 (2004) 1458-1465
8. Todd D.M., Fynn S.P., Walden A.P., Hobbs W.J., Arya S., and Garratt C.J. Repetitive 4-week periods of atrial electrical remodeling promote stability of atrial fibrillation: time course of a second factor involved in the self-perpetuation of atrial fibrillation. Circulation 109 (2004) 1434-1439
9. Vanoverschelde J.L.J., Wijns W., Depré C., Essamri B., Heyndricks S., Borgers M., et al. Mechanisms of chronic regional postischemic dysfunction in humans: new insights from the study on non-infarcted collateral dependent myocardium. Circulation 87 (1993) 1513-1523
10. Allessie M.A., Boyden P.A., Camm A.J., Kléber A.G., Lab M.J., Legato M.J., et al. Pathophysiology and prevention of atrial fibrillation. Circulation 103 (2001) 769-777
11. Thomas S.A., Fallavollita J.A., Suzuki G., Borgers M., and Canty J.M. Dissociation of regional adaptations to ischemia and global myolysis in an accelerated swine model of chronic hibernating myocardium. Circ. Res. 91 (2004) 970-977
12. Maes A., Flameng W., Nuyts J., Borgers M., Shivalkar B., Ausma J., et al. Histological alterations in chronically hypoperfused myocardium. Correlation with PET findings. Circulation 90 (1994) 735-745
13. Decker R.S., Decker M.L., Nakamura S., Zhao Y.S., Hedjbeli S., Harris K.R., and Klocke F.J. Hsc73-tubulin complex formation during low-flow ischemia in canine myocardium. Am. J. Physiol. Heart Circ. Physiol. 283 (2002) H1322-H1333
14. Lutsch G., Vetter R., Offhauss U., Wieske M., Gröne H.J., Klemenz R., et al. Abundance and location of the small heat shock proteins Hsp25 and aB-crystallin in rat and human heart. Circulation 96 (1997) 3466-3476
15. Bryantsev A.L., Loktionova S.A., Ilyinskaya O.P., Tararak E.M., Kampinga H.H., and Kabakow A.E. Distribution, phosphorylation, and activities of Hsp25 in heat-stressed H9c2 myoblasts: a functional link to cytoprotection. Cell Stress Chaperones 7 (2002) 146-155
16. Van den Klundert M., Gijsen M.L., van den IJssel P.R., Snoeckx L.H., and de Jong W.W. Alpha B-crystallin and hsp25 in neonatal cardiac cells-Differences in cellular localization under stress conditions. Eur. J. Cell Biol. 75 (1998) 38-45
17. Hoch B., Lutsch G., Schlegel W.P., Stahl J., Wallukat G., Bartel S., et al. HSP25 in isolated perfused rat hearts: localization and response to hyperthermia. Mol. Cell Biochem. 160-161 (1996) 231-239
18. Sanada S., Kitakaze M., Papst P.J., Hatanaka K., Asanuma H., Aki T., et al. Role of phasic dynamism of p38 mitogen-activated protein kinase activation in ischemic preconditioning of the canine heart. Circ. Res. 88 (2001) 175-180
19. Lavoie J.N., Lambert H., Hickey E., Weber L.A., and Landry J. Modulation of cellular thermoresistance and actin filament stability accompanies phosphorylation-induced changes in the oligomeric structure of heat shock protein 27. Mol. Cell Biol. 15 (1995) 505-516
20. Brundel B.J.J.M., Kampinga H.H., and Henning R.H. Calpain inhibition prevents pacing induced cellular remodeling in a HL-1 myocyte model for atrial fibrillation. Cardiovasc. Res. 62 (2004) 521-528
21. Yang Z., Shen W., Rottman J.N., Wikswo J.P., and Murray K.T. Rapid stimulation causes electrical remodeling in cultured atrial myocytes. J. Mol. Cell Cardiol. 38 (2005) 299-308
22. Hirakawa T., Rokutan K., Nikawa T., and Kishi K. Geranylgeranylacetone induces heat shock proteins in cultured guinea pig gastric mucosal cells and rat gastric mucosa. Gastroenterology 111 (1996) 345-357
23. Ooie T., Takahashi N., Saikawa T., Nawata T., Arikawa M., Yamanaka K., et al. Single oral dose of geranylgeranylacetone induces heat-shock protein 72 and renders protection against ischemia/reperfusion injury in rat heart. Circulation 104 (2001) 1837-1843
24. Katsuno M., Sang C., Adachi H., Minamiyama M., Waza M., Tanaka F., et al. Pharmacological induction of heat-shock proteins alleviates polyglutamine-mediated motor neuron disease. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 16801-16806
25. Claycomb W.C., Lanson N.A., Stallworth B.S., Egeland D.B., Delcarpio J.B., Bahinski A., et al. HL-1 cells: a cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 2979-2984
26. Gallagher M.M., and Camm A.J. Classification of atrial fibrillation. Pacing Clin. Electrophysiol. 20 (1997) 1603-1605
27. Brundel B.J.J.M., Van Gelder I.C., Henning R.H., Tuinenburg A.E., Tieleman R.G., Wietses M., et al. Ion channel remodeling is related to intra-operative atrial refractory periods in patients with paroxysmal and persistent atrial fibrillation. Circulation 103 (2001) 684-690
28. Brundel B.J.J.M., Ausma J., Van Gelder I.C., Van Der Want J.J.L., Van Gilst W.H., Crijns H.J.G.M., et al. Activation of proteolysis by calpains and structural changes in human paroxysmal and persistent atrial fibrillation. Cardiovasc. Res. 54 (2002) 380-389
29. Brundel B.J.J.M., Van Gelder I.C., Henning R.H., Tuinenburg A.E., Deelman L.E., Tieleman R.G., et al. Gene expression of proteins influencing the calcium homeostasis in patients with persistent and paroxysmal atrial fibrillation. Cardiovasc. Res. 42 (1999) 443-454
30. Kieran D., Kalmar B., Dick J.R., Riddoch-Contreras J., Burnstock G., and Greensmith L. Treatment with arimoclomol, a coinducer of heat shock proteins, delays disease progression in ALS mice. Nat. Med. 10 (2004) 402-405
31. Soti C., Nagy E., Giricz Z., Vigh L., Csermely P., and Ferdinandy P. Heat shock proteins as emerging therapeutic targets. Br. J. Pharmacol. 146 (2005) 769-780
32. Sun H., Chartier D., Leblanc N., and Nattel S. Intracellular calcium changes and tachycardia-induced contractile dysfunction in canine atrial myocytes. Cardiovasc. Res. 49 (2001) 751-761
33. Somara S., and Bitar K.N. Tropomyosin interacts with phosphorylated Hsp27 in agonist-induced contraction of smooth muscle. Am. J. Physiol. Cell Physiol. 286 (2004) C1290-C1301
34. Moretti A., Weig H.J., Ott T., Seyfarth M., Holthoff H.P., Grewe D., et al. Essential myosin light chain as a target for caspase-3 in failing myocardium. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 11860-11865
35. Communal C., Sumandea M., De Tombe P., Narula J., Solaro R.J., and Hajjar R.J. Functional consequences of caspase activation in cardiac myocytes. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 6252-6256
36. Kampinga H.H. Thermotolerance in mammalian cells. Protein denaturation and aggregation, and stress proteins. J. Cell Sci. 104 (1993) 11-17
37. Demirel H.A., Hamilton K.L., Shanely R.A., Tumer N., Koroly M.J., and Powers S.K. Age and attenuation of exercise-induced myocardial HSP72 accumulation. Am. J. Physiol. Heart Circ. Physiol. 285 (2003) H1609-H1615
38. Benjamin I.J., Shelton J., Garry D.J., and Richardson J.A. Temporospatial expression of the small HSP/alpha B-crystallin in cardiac and skeletal muscle during mouse development. Dev. Dyn. 208 (1997) 75-84
39. Knowlton A.A., Kapadia S., Torre-Amione G., Durand J.B., Bies R., Young J., et al. Differential expression of heat shock proteins in normal and failing human hearts. J. Mol. Cell Cardiol. 30 (1998) 811-818